02666 UNI MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.37X | Oper Margin | 20.7% |
|---|---|---|---|
| LT Debt/Equity | 147.6% | Net Margin | 14.4% |
| Total Debt/Equity | 250.1% | Return on Equity | 11.2% |
| Price/Book | 0.55X | Return on Assets | 2.6% |
| (HKD 5.900) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 2,400.69 | 2,160.76 | 2,227.46 | 2,117.29 | 2,244.67 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.1 | -3.0 | +5.2 | -5.7 | +14.8 |
| Earnings Per Share (HKD) | 1.258 | 1.142 | 1.178 | 1.119 | 1.207 |
| Earnings Per Share Growth (%) | +10.1 | -3.0 | +5.2 | -7.3 | +5.9 |
| Dividend Per Share (HKD) | 0.360 | 0.350 | 0.350 | 0.340 | 0.360 |
| P/E* (X) | 4.69 | 5.17 | 5.01 | 5.27 | 4.89 |
| Yield (%) | 6.10 | 5.93 | 5.93 | 5.76 | 6.10 |
| Dividend Share (%) | 28.62 | 30.64 | 29.72 | 30.38 | 29.83 |
| Book NAV (HKD) | 10.655 | 9.657 | 9.135 | 8.287 | 8.473 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 14,940 | 13,663 | +9.3 | 13,650 |
| Operating Result | 3,028 | 2,881 | +5.1 | 2,860 |
| Associates | -9.092 | 26.564 | -134.2 | 6.38 |
| Profit Before Taxation | 3,019 | 2,907 | +3.9 | 2,866 |
| Taxation | 701.556 | 648.785 | +8.1 | 667.141 |
| Profit /( Loss) After Taxation | 2,318 | 2,258 | +2.7 | 2,199 |
| Minority Interests | 108.641 | 154.377 | -29.6 | 88.735 |
| Net Profit | 2,157 | 2,032 | +6.2 | 2,021 |
| Earnings Per Share () | 1.2580 | 1.1423 | +10.1 | 1.1776 |
| Dividend Per Share () | 0.3600 | 0.3500 | +2.9 | 0.3500 |
| Announcement Date | 2026-03-25 | 2025-03-26 | NA | 2024-03-27 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
